Dawid Jaskólski

Dawid Jaskólski

Auto-generated profile, based on publicly available information

Dawid Jaskólski

University Clinical Centre, Gdańsk, ul. Dębinki 7, 80-952 Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2024 in Rheumatology International
Verified
Journal Article
Open access
PDF file
IKIga Kościńska-Shukla
Iga Kościńska-Shukla
MJMarta Jaskólska
Marta Jaskólska
CMChylińska Magdalena
Chylińska Magdalena
DJDawid Jaskólski
Dawid Jaskólski
MSMariusz Siemiński
Mariusz Siemiński
MCMichal Chmielewski
Michal Chmielewski
Introduction: Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by lymphocytic infiltrates in the exocrine glands. Carpal tunnel syndrome (CTS) is suggested to be more frequent among SS patients than in the general population. The aim of this study was to seek associations between the CTS and the laboratory and clinical findings of SS patients. Methods: Fifty patients diagnosed with primary SS (pSS) were examined. Clinical evaluation by a rheumatologist and electrophysiological studies were conducted. Data on laboratory tests results was collected. Control group consisted of 50 sex and age-matched individuals with osteoarthritis (OA). Results: Out of 50 patients in the study group 27 (54%) were diagnosed with CTS. The prevalence of CTS among 50 individuals in the control group was 8%. Among pSS patients with CTS the joint involvement was not more common than in those from the non-CTS group [15 vs. 13 (p = 0.945)]. There was an expected difference in sleep disorders [18 vs. 9 (p = 0.012)] and paresthesia [23 vs. 13 (p = 0.024)]. The major finding was a significant difference in elevated beta2-microglobulin (B2MG) [23 vs. 13 (p = 0.024)]. Other studied factors, suggested in the literature as significant in the pSS-related neuropathy, were not statistically different between the groups. Conclusion: Our study confirms that CTS is more prevalent among pSS patients than in the general population and suggests that a new approach is required towards the pathogenesis of this phenomenon. We hypothesize that CTS is more associated with an overall disease activity than joint involvement as such.

Verified
Journal Article
Open access
PDF file
IKIga Kościńska-Shukla
Iga Kościńska-Shukla
ASArkadiusz Szarmach
Arkadiusz Szarmach
CMChylińska Magdalena
Chylińska Magdalena
DJDawid Jaskólski
Dawid Jaskólski
MCMichal Chmielewski
Michal Chmielewski
MJMarta Jaskólska
Marta Jaskólska
Peripheral neuropathy constitutes a prevalent, albeit underrecognized, extraglandular manifestation of Sjögren’s disease (SjD). Carpal tunnel syndrome (CTS) commonly coexists with SjD; however, the efficacy of standard CTS treatments in this population remains insufficiently characterized. This study evaluated the clinical and biological response to local corticosteroid injection in CTS patients with and without SjD and explored factors potentially associated with treatment outcomes. Twenty patients with SjD and CTS diagnosed based on typical clinical symptoms and supportive ultrasonographic findings and 19 control subjects with idiopathic CTS underwent ultrasound-guided corticosteroid injection. Median nerve cross-sectional area (CSA), the Boston Carpal Tunnel Questionnaire (BCTQ), and the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire were assessed before treatment and 4 weeks after injection. Patients with SjD additionally underwent comprehensive clinical, laboratory, neurophysiological, and patient-reported outcome assessments. Patients with SjD appeared to demonstrate a significantly greater reduction in median nerve CSA following corticosteroid injection compared with controls (mean reduction: 0.46 vs. 0.31 mm2; p = 0.006, Cohen’s d = 0.96, CI90% [0.51, 1.49]). Despite this favorable biological response, clinical improvement was significantly smaller in the SjD group. Patients without SjD exhibited greater improvement in both the BCTQ Symptom Severity Scale (p = 0.021) and Functional Status Scale (p = 0.033), whereas changes in DASH scores did not differ significantly between groups. Patients with concomitant peripheral neuropathies experienced significantly poorer BCTQ improvement than those with isolated CTS, suggesting that neurological comorbidity may contribute to treatment resistance. No significant associations were identified between treatment response and fibromyalgia status or ESSPRI domains. Among quality-of-life measures, only the SF-36 General Health domain differed significantly between neuropathy types. Patients with SjD and CTS exhibit a dissociation between structural improvement of the median nerve and subjective symptom relief after corticosteroid injection. These findings suggest that mechanisms beyond local nerve compression, including coexisting peripheral neuropathy and potentially altered pain processing, may contribute to persistent symptoms. Comprehensive neurological assessment and multidimensional outcome evaluation may improve identification of SjD patients at risk of suboptimal response to conventional CTS therapies.

1 June 2022 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
MJMarta Jaskólska
Marta Jaskólska
DJD. Jaskólski
D. Jaskólski
MZM. Ziętkiewicz
M. Ziętkiewicz
AVAlessandro Viti
Alessandro Viti
ZZZ. Zdrojewski
Z. Zdrojewski
Background Sjogren’s Syndrome (SS) is a common autoimmunological disorder characterized by infiltration of exocrine glands by autoreactive immune cells that lead to the disease’s two most common symptoms — dry eyes and a dry mouth, also known as sicca syndrome. The etiopathogenesis considers the coexistence of genetic predisposition and environmental factors, such as viral infections or sex hormones imbalance. Objectives The aim of the study was to determine whether major stressful life events are also risk factors for developing SS. Methods We performed a matched case-control study. Cases were patients with an established diagnosis of primary SS (pSS) within the previous five years. Controls were patients with osteoarthritis in whom systemic connective tissue disease has been ruled out. Data on major stressful life events were collected using the modified Holmes-Rahe stress scale. Data were collected for the period of the year before the disease onset. Results 100 patients were enrolled in the study (pSS group = 50, control group = 50), mean age was 55.8±10.4 years for pSS and 61.3±9.59 years for control group, in both groups 96 % of patients were female. pSS patients had significantly higher total score on Holmes-Rahe stress scale within the preceding 1 year before the onset of disease symptoms than control group (pSS group = 152±66.3 vs control group = 50±54.6; p<0.001). In pSS group 50 % of patients reported the subjective impression that the symptoms were caused by stress, while in control group it was 12 % (p<0.001). The most frequently mentioned life events in the pSS group were divorce or marital separation, death or change in health of family member and stress related to work. Conclusion Patients with pSS are significantly more likely to have had a major stressful life event within the preceding 1 year before the disease onset. The relationship between stress and the occurrence of many diseases and their exacerbations is well documented, especially within autoimmune diseases. Stress is a ubiquitous problem these days, therefore it is of fundamental importance to understand the biological mechanisms underlying its influence on the development of diseases. It is crucial to properly recognize the stressful situation in the patient’s life and undertake appropriate interventions in order to prevent health consequences. References [1]Sandhya P, Kurien BT, Danda D, Scofield RH. Update on Pathogenesis of Sjogren’s Syndrome. Curr Rheumatol Rev. 2017;13(1):5-22. doi: 10.2174/1573397112666160714164149. PMID: 27412602; PMCID: PMC5280579. [2]Sharif K, Watad A, Coplan L, Lichtbroun B, Krosser A, Lichtbroun M, Bragazzi NL, Amital H, Afek A, Shoenfeld Y. The role of stress in the mosaic of autoimmunity: An overlooked association. Autoimmun Rev. 2018 Oct;17(10):967-983. doi: 10.1016/j.autrev.2018.04.005. Epub 2018 Aug 14. PMID: 30118900. [3]Skopouli FN, Katsiougiannis S. How stress contributes to autoimmunity-lessons from Sjögren’s syndrome. FEBS Lett. 2018 Jan;592(1):5-14. doi: 10.1002/1873-3468.12933. Epub 2017 Dec 22. PMID: 29223133. [4]Roberts AL, Malspeis S, Kubzansky LD, Feldman CH, Chang SC, Koenen KC, Costenbader KH. Association of Trauma and Posttraumatic Stress Disorder With Incident Systemic Lupus Erythematosus in a Longitudinal Cohort of Women. Arthritis Rheumatol. 2017 Nov;69(11):2162-2169. doi: 10.1002/art.40222. Epub 2017 Oct 12. PMID: 28929625; PMCID: PMC5659907. [5]Lee YC, Agnew-Blais J, Malspeis S, Keyes K, Costenbader K, Kubzansky LD, Roberts AL, Koenen KC, Karlson EW. Post-Traumatic Stress Disorder and Risk for Incident Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2016 Mar;68(3):292-8. doi: 10.1002/acr.22683. PMID: 26239524; PMCID: PMC4740283. [6]Warren S, Greenhill S, Warren KG. Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship. J Chronic Dis. 1982;35(11):821-31. doi: 10.1016/0021-9681(82)90047-9. PMID: 7142361. Disclosure of Interests None declared